Inogen (INGN) Gross Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 190.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190.00 |
| Dec 31, 2025 | 966.00 |
| Sep 30, 2025 | 411.00 |
| Jun 30, 2025 | 5.00 |
| Mar 31, 2025 | 66.00 |
| Dec 31, 2024 | -519.00 |
| Sep 30, 2024 | -1,235.00 |
| Jun 30, 2024 | -759.00 |
| Mar 31, 2024 | -768.00 |
| Dec 31, 2023 | -894.00 |
| Sep 30, 2023 | -419.00 |
| Jun 30, 2023 | -921.00 |
| Mar 31, 2023 | -356.00 |
| Dec 31, 2022 | -953.00 |
| Sep 30, 2022 | -659.00 |
| Jun 30, 2022 | -494.00 |
| Mar 31, 2022 | -568.00 |
| Dec 31, 2021 | 15.00 |
| Sep 30, 2021 | 767.00 |
| Jun 30, 2021 | 589.00 |
| Mar 31, 2021 | 400.00 |
| Dec 31, 2020 | -218.00 |
| Sep 30, 2020 | -365.00 |
| Jun 30, 2020 | 68.00 |
| Mar 31, 2020 | -289.00 |
| Dec 31, 2019 | -557.00 |
| Sep 30, 2019 | 103.00 |
| Jun 30, 2019 | 164.00 |
| Mar 31, 2019 | -27.00 |
| Dec 31, 2018 | 81.00 |
| Sep 30, 2018 | 371.00 |
| Jun 30, 2018 | 256.00 |
| Mar 31, 2018 | 25.00 |
| Dec 31, 2017 | 77.00 |
| Sep 30, 2017 | -179.00 |
| Jun 30, 2017 | -50.00 |
| Mar 31, 2017 | -148.00 |
| Dec 31, 2016 | -294.00 |
| Sep 30, 2016 | -258.00 |
| Jun 30, 2016 | -681.00 |
| Mar 31, 2016 | -205.00 |